Ann Tovcimak

Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI

C.-L. Chin, Ann Tovcimak, Vincent P. Hradil et al. · British Journal of Pharmacology · 2007 · 97 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Characterization of a Cannabinoid CB2 Receptor-Selective Agonist, A-836339 [2,2,3,3-Tetramethyl-cyclopropanecarboxylic Acid [3-(2-Methoxy-ethyl)-4,5-dimethyl-3 H-thiazol-(2 Z)-ylidene]-amide], Using in Vitro Pharmacological Assays, in Vivo Pain Models, and Pharmacological Magnetic Resonance Imaging

Betty Yao, Gin C. Hsieh, A.V. Daza et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 91 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Potentiation of analgesic efficacy but not side effects: Co-administration of an α4β2 neuronal nicotinic acetylcholine receptor agonist and its positive allosteric modulator in experimental models of pain in rats

Chang Zhu, Chih‐Liang Chin, Nathan R. Rustay et al. · Biochemical Pharmacology · 2011 · 51 citations

Medicine, Neuroscience, Pharmacology +17

Efficacies of ABT-773, a New Ketolide, against Experimental Bacterial Infections

Michael J. Mitten, Jonathan A. Meulbroek, Michael A. Nukkala et al. · Antimicrobial Agents and Chemotherapy · 2001 · 28 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Pharmacological modulation of brain activity in a preclinical model of osteoarthritis

Jaymin Upadhyay, Scott Baker, Rajasimhan Rajagovindan et al. · NeuroImage · 2012 · 26 citations

Medicine, Neuroscience, Pharmacology +7